Organic Anion/Cation Transporters: From Molecular Insights to Clinical Impact and Nanotechnology Innovation
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.6c00480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Qi Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430022, China. Hauptthemen laut MEDLINE: Organic Cation Transport Proteins, Organic Anion Transporters. Die Arbeit nennt 124 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Tongji Medical College, Huazhong University of Science and Technology.
Abstract (Originalsprache)
Organic anion and cation transporters (OATs and OCTs), members of the solute carriers (SLC)22 family, are critically involved in the transport of endogenous metabolites and xenobiotics across key barriers in the kidney, liver, and choroid plexus. While their role in small-molecule drug pharmacokinetics, drug–drug interactions, and clinical issues is well established, their potential interaction with nanomaterials remains a largely unexplored frontier. This is particularly significant given that the long-term retention of nanomaterials in vivo poses a major challenge to their clinical translation. We hypothesize that OATs and OCTs recognize specific nanomaterials as substrates, thereby mediating a novel and active elimination pathway that transcends conventional size-dependent filtration. This review systematically delineates the structural and functional basis of major OAT/OCT subtypes (e.g., OAT1–3, URAT1, OCT1–3) to establish a conceptual framework and then integrates this with current clinical applications and a brief discussion on the primary biological elimination routes of nanomaterials. By bridging these fields, this review aims to prompt a paradigm shift in nanomedicine design, advocating for the rational engineering of nanomaterial properties (e.g., size, charge, surface, shape) to engage with these transport systems. Ultimately, leveraging OAT/OCT pathways may unlock novel strategies to precisely control nanomedicine distribution and enhance clearance, thereby accelerating safe and effective clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430022, China.
- Hubei Key Laboratory of Molecular Imaging, Wuhan430022, China.
- Key Laboratory of Biological Targeted Therapy, The Ministry of Education, Wuhan430022, China.
- Hubei Provincial Clinical Medical Research Center for Medical Imaging, Wuhan, Hubei430022, China.
ORCID-Profile: Dawei Jiang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Tongji Medical College, Huazhong University of Science and Technology
- Department of Science and Technology of Hubei Province
Zitieren
APA
Guo, Q., Long, X., Jiang, D., & Liu, H. (2026). Organic Anion/Cation Transporters: From Molecular Insights to Clinical Impact and Nanotechnology Innovation. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00480
Vancouver
Guo Q, Long X, Jiang D, Liu H. Organic Anion/Cation Transporters: From Molecular Insights to Clinical Impact and Nanotechnology Innovation. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c00480
BibTeX
@article{Guo2026,
author = {Guo, Qi and Long, Xingru and Jiang, Dawei and Liu, Huanhuan},
title = {Organic Anion/Cation Transporters: From Molecular Insights to Clinical Impact and Nanotechnology Innovation},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.6c00480}
}
EUVIMED